Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Handheld ultrasound could bring lifesaving scans to war zones

NCT ID NCT07677553

Knowledge-focused Sponsor: Meir Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study explores whether a short, hands-on training course can help community doctors in conflict-affected Syria use portable ultrasound devices to diagnose patients. Nine physicians from five village clinics attended a two-day course focused on heart, lung, and trauma scans. After training, each clinic received a handheld ultrasound machine, and doctors uploaded their scans for remote expert review. The goal is to see if this approach is practical and improves confidence and care in areas where standard imaging is unavailable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Point-of-care ultrasound (POCUS) training and handheld ultrasound device
What this could lead to
If successful, this approach could help bring basic diagnostic imaging to remote and war-torn areas, improving care for people who otherwise have no access.
What could go wrong
This is a very small pilot study with only 9 doctors, so results may not apply broadly. The conflict setting also makes it hard to ensure consistent follow-up and device maintenance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 9 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Nine physicians from five community clinics serving villages in a region of Syria that cannot be further specified for security reasons participated in the program. Participants represented several medical specialties and were selected in collaboration with IFA based on their involvement in frontline community care and their anticipated ability to integrate POCUS into clinical practice.

Ages

18 to 99 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria:Nine physicians from five community clinics serving villages in a region of Syria that cannot be further specified for security reasons participated in the program. Participants represented several medical specialties and were selected in collaboration with IFA based on their involvement in frontline community care and their anticipated ability to integrate POCUS into clinical practice. \- Exclusion Criteria:None \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Training are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Training

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Meir Medical Center

    RECRUITING

    Kfar Saba, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.